Related Experiment Video
Updated: May 13, 2026
06:21
Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration
Published on: April 27, 2018
Sprouty2, PTEN, and PP2A interact to regulate prostate cancer progression
Rachana Patel1, Meiling Gao, Imran Ahmad
1The Beatson Institute for Cancer Research, Glasgow, United Kingdom.
The Journal of Clinical Investigation
|February 26, 2013
Summary
Loss of SPRY2 in prostate cancer activates a tumor suppressor checkpoint, but PTEN loss cooperates with SPRY2 deficiency to drive tumor growth and metastasis.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Prostate cancer progression involves concurrent activation of RAS/ERK and PI3K/AKT pathways.
- Negative regulators like sprouty2 (SPRY2), protein phosphatase 2A (PP2A), and phosphatase and tensin homolog (PTEN) are frequently inactivated.
Purpose of the Study:
- To elucidate the molecular basis of cooperation between genetic alterations in SPRY2, PTEN, and PP2A in prostate cancer.
- To investigate the role of SPRY2 deficiency in tumor suppressor checkpoints and its interaction with PTEN loss.
Main Methods:
- Utilized murine prostate cancer models to study the synergistic effects of Spry2 and Pten deficiency.
- Analyzed the activation of AKT, ERK, PP2A, and GSK3β pathways in response to genetic alterations.
- Correlated SPRY2, PTEN, and PP2A expression levels in human prostate cancer samples.
Main Results:
- SPRY2 deficiency alone activates AKT and ERK but is insufficient for tumorigenesis, instead triggering a PP2A-dependent tumor suppressor checkpoint.
- PTEN haploinsufficiency synergizes with Spry2 deficiency in mouse models, driving prostate tumorigenesis and metastasis.
- Loss of SPRY2 expression strongly correlates with loss of PTEN and/or PP2A subunits in human prostate cancer.
Conclusions:
- Loss of PTEN cooperates with SPRY2 deficiency by bypassing a novel tumor suppressor checkpoint, promoting prostate cancer progression.
- The interplay between SPRY2, PTEN, and PP2A is a critical determinant of prostate cancer progression.
- Assessing the status of SPRY2, PTEN, and PP2A may aid in stratifying patients for targeted therapies and chemoprevention.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...